Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosis.

Cugno M, Scott CF, Salerno F, Lorenzano E, Müller-Esterl W, Agostoni A, Colman RW.

Thromb Haemost. 1999 Nov;82(5):1428-32.

PMID:
10595632
2.

Hypotensive reactions during transfusion: is bradykinin the culprit?

Colman RW, Scott CF.

Transfusion. 1999 Jan;39(1):107-9. No abstract available.

PMID:
9920175
4.
5.
6.

More on kininogen measurements in platelet concentrates that are white cell (WBC) reduced with WBC-reduction filters.

Colman RW, Scott CF, Brandwein H, Whitbread J.

Transfusion. 1996 Oct;36(10):939-41. No abstract available.

PMID:
8863787
7.

When and where is factor XI activated by thrombin?

Colman RW, Scott CF.

Blood. 1996 Mar 1;87(5):2089. No abstract available.

8.

Prognostic value of assessing contact system activation and factor V in systemic inflammatory response syndrome.

Pixley RA, Zellis S, Bankes P, DeLa Cadena RA, Page JD, Scott CF, Kappelmayer J, Wyshock EG, Kelly JJ, Colman RW.

Crit Care Med. 1995 Jan;23(1):41-51.

PMID:
7528118
9.

Preparation and characterization of interleukin-2-gelonin conjugates made using different cross-linking reagents.

McIntyre GD, Scott CF Jr, Ritz J, Blättler WA, Lambert JM.

Bioconjug Chem. 1994 Jan-Feb;5(1):88-97.

PMID:
8199239
10.

Genetic basis of total kininogen deficiency in Williams' trait.

Cheung PP, Kunapuli SP, Scott CF, Wachtfogel YT, Colman RW.

J Biol Chem. 1993 Nov 5;268(31):23361-5.

12.
13.

In vitro inhibition of a variety of human immunodeficiency virus isolates by a broadly reactive, V3-directed heteroconjugate antibody.

Higgins PJ, Paradis T, Potts BJ, White-Scharf ME, Rusche JR, Scott CF.

J Infect Dis. 1992 Jul;166(1):198-202.

PMID:
1607697
14.
15.

Mechanism of the participation of the contact system in the Vroman effect. Review and summary.

Scott CF.

J Biomater Sci Polym Ed. 1991;2(3):173-81. Review.

PMID:
1854683
16.

Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain.

Scott CF Jr, Silver S, Profy AT, Putney SD, Langlois A, Weinhold K, Robinson JE.

Proc Natl Acad Sci U S A. 1990 Nov;87(21):8597-601.

17.

Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4.

Sharpe RJ, Byers HR, Scott CF, Bauer SI, Maione TE.

J Natl Cancer Inst. 1990 May 16;82(10):848-53.

PMID:
1692094
18.

Cytotoxicity of gelonin and its conjugates with antibodies is determined by the extent of their endocytosis.

Goldmacher VS, Scott CF, Lambert JM, McIntyre GD, Blättler WA, Collnhson AR, Stewart JK, Chong LD, Cook S, Slayter HS, et al.

J Cell Physiol. 1989 Oct;141(1):222-34.

PMID:
2528553
19.

Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells.

Scott CF Jr, Bolender S, McIntyre GD, Holldack J, Lambert JM, Venkatesh YP, Morimoto C, Ritz J, Schlossman SF.

J Immunol. 1989 Jun 1;142(11):4105-12.

PMID:
2565930
20.
21.

Effect of heparin on the inhibition of the contact system enzymes.

Colman RW, Scott CF, Pixley RA, de la Cadena RA.

Ann N Y Acad Sci. 1989;556:95-103.

PMID:
2786690
22.

Semisynthetic arginine-15-aprotinin, an improved inhibitor for human plasma kallikrein.

Tschesche H, Beckmann J, Mehlich A, Feldmann A, Wenzel HR, Scott CF, Colman RW.

Adv Exp Med Biol. 1989;247B:15-21. No abstract available.

PMID:
2481943
23.

Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.

Carvalho AC, DeMarinis S, Scott CF, Silver LD, Schmaier AH, Colman RW.

J Lab Clin Med. 1988 Aug;112(2):270-7.

PMID:
3397629
24.
25.

View on animal rights that education will be the only solution to the problem.

Scott CF.

Physiologist. 1988 Jun;31(3):53. No abstract available.

PMID:
3406146
26.

A simple and accurate microplate assay for the determination of factor XI in plasma.

Scott CF, Colman RW.

J Lab Clin Med. 1988 Jun;111(6):708-14.

PMID:
3373114
27.

Requirements for the construction of antibody heterodimers for the direction of lysis of tumors by human T cells.

Scott CF Jr, Blättler WA, Lambert JM, Kalish RS, Morimoto C, Schlossman SF.

J Clin Invest. 1988 May;81(5):1427-33.

28.

Mechanism of transient adsorption of fibrinogen from plasma to solid surfaces: role of the contact and fibrinolytic systems.

Brash JL, Scott CF, ten Hove P, Wojciechowski P, Colman RW.

Blood. 1988 Apr;71(4):932-9.

29.

Recombinant alpha 1-antitrypsin Pittsburgh attenuates experimental gram-negative septicemia.

Colman RW, Flores DN, De La Cadena RA, Scott CF, Cousens L, Barr PJ, Hoffman IB, Kueppers F, Fisher D, Idell S, et al.

Am J Pathol. 1988 Feb;130(2):418-26.

30.

Immunotoxins containing single-chain ribosome-inactivating proteins.

Lambert JM, Blättler WA, McIntyre GD, Goldmacher VS, Scott CF Jr.

Cancer Treat Res. 1988;37:175-209. Review.

PMID:
2908625
31.

Human T cells can be directed to lyse tumor targets through the alternative activation/T11-E rosette receptor pathway.

Scott CF Jr, Lambert JM, Kalish RS, Morimoto C, Schlossman SF.

J Immunol. 1988 Jan 1;140(1):8-14.

PMID:
2891767
32.

A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate.

Scott CF, Pixley RA, Colman RW.

Thromb Res. 1987 Dec 15;48(6):685-700.

PMID:
3501619
34.

Evaluation of a microassay for human plasma prekallikrein.

De La Cadena RA, Scott CF, Colman RW.

J Lab Clin Med. 1987 May;109(5):601-7.

PMID:
3646287
36.

Lack of effect of heparin on factor XIa.

Colman RW, Scott CF.

Blood. 1987 Feb;69(2):703-4. No abstract available.

37.

The antileukemic efficacy of an immunotoxin composed of a monoclonal anti-Thy-1 antibody disulfide linked to the ribosome-inactivating protein gelonin.

Scott CF Jr, Goldmacher VS, Lambert JM, Chari RV, Bolender S, Gauthier MN, Blättler WA.

Cancer Immunol Immunother. 1987;25(1):31-40.

PMID:
3496157
38.

The pharmacokinetics and toxicity of murine monoclonal antibodies and of gelonin conjugates of these antibodies.

Scott CF Jr, Lambert JM, Goldmacher VS, Blatter WA, Sobel R, Schlossman SF, Benacerraf B.

Int J Immunopharmacol. 1987;9(2):211-25.

PMID:
3495503
39.

Appropriate animal models for research on blood in contact with artificial surfaces.

Scott CF.

Ann N Y Acad Sci. 1987;516:636-7. No abstract available.

PMID:
3439749
40.

Initiation of blood coagulation at artificial surfaces.

Colman RW, Scott CF, Schmaier AH, Wachtfogel YT, Pixley RA, Edmunds LH Jr.

Ann N Y Acad Sci. 1987;516:253-67. No abstract available.

PMID:
3439730
41.

Human factor XIa cleaves fibrinogen: effects on structure and function.

Scott CF, Mentzer RL, Budzynski AZ, Colman RW.

Arch Biochem Biophys. 1986 Sep;249(2):480-8.

PMID:
2944482
42.

High molecular weight kininogen is an inhibitor of platelet calpain.

Schmaier AH, Bradford H, Silver LD, Farber A, Scott CF, Schutsky D, Colman RW.

J Clin Invest. 1986 May;77(5):1565-73.

43.
44.

Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf.

Scott CF, Carrell RW, Glaser CB, Kueppers F, Lewis JH, Colman RW.

J Clin Invest. 1986 Feb;77(2):631-4.

45.

T cell development in B cell-deficient mice. IV. The role of B cells as antigen-presenting cells in vivo.

Hayglass KT, Naides SJ, Scott CF Jr, Benacerraf B, Sy MS.

J Immunol. 1986 Feb 1;136(3):823-9.

PMID:
2416835
46.

Cleavage of human high molecular weight kininogen by factor XIa in vitro. Effect on structure and function.

Scott CF, Silver LD, Purdon AD, Colman RW.

J Biol Chem. 1985 Sep 5;260(19):10856-63.

48.

Effect of cleavage of the heavy chain of human plasma kallikrein on its functional properties.

Colman RW, Wachtfogel YT, Kucich U, Weinbaum G, Hahn S, Pixley RA, Scott CF, de Agostini A, Burger D, Schapira M.

Blood. 1985 Feb;65(2):311-8.

49.

Alpha 1-antitrypsin-Pittsburgh: a potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf.

Scott CF, Carrell RW, Glaser CB, Lewis JH, Colman RW.

Trans Assoc Am Physicians. 1985;98:344-51.

PMID:
3879844

Supplemental Content

Loading ...
Support Center